Kirkland & Ellis announced that leading M&A attorneys Graham Robinson, Laura Knoll, and Chadé Severin have joined the Firm as partners. These three partners specialize in public company M&A transactions, with a particular focus on the biotechnology sector.
Robinson led transactions for some of the largest pharmaceutical, medical device, and technology companies in the U.S. and globally. He also brings significant experience in the shareholder activism space. He has also helped companies prepare for and respond to unsolicited acquisition proposals, as well as deal with activist investors. Plus, he also provides counsel to boards of directors and special committees on corporate governance matters and internal investigations.
Knoll focuses on mergers and acquisitions and related corporate advice, guiding both public and private companies through transformative events and critical governance matters. And her clients have included companies across biopharmaceutical, technology and adjacent sectors.
Severin’s practice focuses on mergers and acquisitions for public and private companies primarily in the pharmaceutical, biotechnology and technology industries. And she has advised boards of directors on many transactions involving controlling stockholders, both on behalf of the controlled company and the controller.
KEY QUOTES:
“Graham, Laura and Chadé are among the nation’s leading M&A lawyers and the market-leaders for biotech M&A. We’re thrilled that they are joining Kirkland and adding more strength to our leading M&A practice.”
Jon A. Ballis, Chairman of Kirkland & Ellis
“I could not be more excited for this next chapter of my career. The Kirkland M&A platform is a great fit for our practice, and I look forward to contributing to the continued success of the Firm’s M&A team and the Boston office.”
Graham Robinson
